Vosoritide Treatment in Children with Hypochondroplasia: Three-Year Results from a Phase 2 Extension Trial. // Genetics in Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S1098360026011214?dgcid=rss_sd_all
Vosoritide Treatment in Children with Hypochondroplasia: Three-Year Results from a Phase 2 Extension Trial. Genetics in Medicine. https://www.sciencedirect.com/science/article/pii/S1098360026011214?dgcid=rss_sd_all
“Vosoritide Treatment in Children with Hypochondroplasia: Three-Year Results from a Phase 2 Extension Trial.” Genetics in Medicine.
@article{article46860,
title = {Vosoritide Treatment in Children with Hypochondroplasia: Three-Year Results from a Phase 2 Extension Trial},
journal = {Genetics in Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S1098360026011214?dgcid=rss_sd_all}
}